Antifungal Drugs Market is expected to reach US$ 13,524.2 Mn in 2027

by Sameer Joshi or 31-Jul-2019
     Request For Sample

Report : Antifungal Drugs Market to 2027 - Global Analysis and Forecasts By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection); Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Others); Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis, Others); Dosage form (Drugs, Ointment, Powder, Others), and Geography

Azoles is expected to drive the growth of the global Antifungal Drugs market by drug type segment

According to a new market research study titled ‘Antifungal Drugs Market to 2027 – Global Analysis and Forecasts by Infection, Drug Type, Therapeutic Indication, Dosage Form and Geography. The global Antifungal Drugs market is expected to reach US$ 13,524.2 Mn in 2027 from US$ 10,182.3 Mn in 2018. The market is estimated to grow with a CAGR of 3.2% from 2019-2027. The market is likely to grow due to the rising incidences for the fungal infection of the skin, nails and hair, increasing incidences of cancers, HIV, and hospital-acquired infections and favorable government initiatives to combat the antifungal diseases.

Antifungal Drugs are used for treating common fungal infections such as fungal nail infection, vaginal infection and others that appear on the external surface of the body and other fungal invasive infection that occur inside the tissue of the body or in an internal organ such as lungs and brains. It works against the fungal infection by either killing the fungal cells or by constraining their growth.

Global Antifungal Drugs market was segmented by infection type, drug type, therapeutic indication, and dosage form. On the basis of the infection type, the market is segmented as superficial fungal infection and systemic antifungal infection. Based on the drug type, the Antifungal Drugs market is segmented into echinocandins, azoles, polyenes, allylamines, and others. On the basis of the therapeutic indication, the Antifungal Drugs market is segmented into aspergillosis, dermatophytosis, candidiasis, and others. By dosage form, the market is segmented into drugs, ointment, powder, and others.

The major players operating in the Antifungal Drugs market, Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Merck And Co., Inc., Scynexis Inc., Novartis International AG, Abbott Laboratories, Bayer AG, Glenmark Pharmaceutical, and Glaxosmithkline Plc. among the others.

The report segments the global Antifungal Drugs market as follows:

Global Antifungal Drugs Market – By Infection Type

  • Superficial Fungal Infection
  • Systemic Fungal Infection

Global Antifungal Drugs Market – By Drug Type

  • Echinocandins
  • Azoles
  • Polyenes
  • Allylamines
  • Others

Global Antifungal Drugs Market – By Therapeutic Indication

  • Aspergillosis  
  • Dermatophytosis
  • Candidiasis
  • Others

Global Antifungal Drugs Market – By Dosage Form

  • Drugs
  • Ointment
  • Powder
  • Others

Global Antifungal Drugs Market – By Geography

  • North America
    • U.S
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • U.K
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
  • South & Central America
    • Brazil
    • Argentina

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@reportsweb.com